TP53 and neuroblastoma: Therefore, we performed composite meta-analyses using MYCN-ChIP-Seq data from the MYCN3 cell line [27] with available MYCN-ChIP-Seq data sets for activating histone marks in other MYCN-amplified neuroblastoma cell lines [25] and available p53-ChIP-Seq data sets [28–32].